SPT Labtech (PRIVATE.SPT)

Overall impact
C (58)

Commentary

SPT Labtech is an average overall performer. With a 'C' rating of 58.0 for overall impact (59th percentile compared to all companies), SPT Labtech ranks 35th out of 50 industry peers, behind Agilent, LGC Group, Pace Analytical Services and 31 others, and ahead of Eversana, Flourish Research, Ascential Technologies and 12 others. On top material causes for SPT Labtech's industry (Life Sciences Tools & Services), SPT Labtech performs well in Child and Maternal Health (95.2 score), Child and Maternal Health (95.2), Child and Maternal Health (95.2) and 3 other causes where it received an 'A' score and performs poorly in Reduced Inequality (15.1 score), Accountable Institutions (30.4), Humane Treatment of Animals (19.9) and 4 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause PRIVATE.SPT
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
400
Sector
Health Care
Industry
Life Sciences Tools & Services
Sub-industry
Life Sciences Tools & Services
SASB industry
Medical Equipment & Supplies
Headquarters
United Kingdom
Share classes
PRIVATE.SPT
Description
Manufacturer and designer of automated instrumentation and consumables intended for life science research. The company's portfolio of products minimizes assay volumes, improves workflows, and minimizes costs within drug discovery, structural biology, molecular biology, and genomics, enabling life scientists to increase productivity and accelerate research.
Material causes
Ethos considers the following causes material for SPT Labtech, based on its industry sub-industry Life Sciences Tools & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.